ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals April 6, 2017 “An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III February 13, 2018 CohBar Announces Second Quarter 2017 Financial Results August 14, 2017
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals April 6, 2017
